Company · CIK 1598599

# Innate Pharma SA

| CIK | [1598599](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001598599) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | I0 |
| Listed | IPHA (Nasdaq), IPHYF (OTC) |
| First annual or quarterly report | 2020-04-24 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-276164 | Shelf Effective | 2023-12-20 | 2024-02-06 | 3 |
| 333-252074 | Shelf Effective | 2021-01-13 | 2023-04-26 | 4 |
| 333-233865 | IPO Final prospectus | 2019-09-20 | 2019-10-18 | 4 |

## Filings

 13

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-02-06 | [424B5](https://www.sec.gov/Archives/edgar/data/1598599/000162828024003513/0001628280-24-003513-index.htm) Shelf takedown | 333-276164 | 0001628280-24-003513 |
| 2024-01-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1598599/999999999524000128/9999999995-24-000128-index.htm) Declared effective | 333-276164 | 9999999995-24-000128 |
| 2023-12-20 | [F-3](https://www.sec.gov/Archives/edgar/data/1598599/000162828023042262/0001628280-23-042262-index.htm) Shelf registered | 333-276164 | 0001628280-23-042262 |
| 2023-04-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1598599/000162828023013213/0001628280-23-013213-index.htm) Shelf takedown | 333-252074 | 0001628280-23-013213 |
| 2022-05-03 | [424B5](https://www.sec.gov/Archives/edgar/data/1598599/000162828022012012/0001628280-22-012012-index.htm) Shelf takedown | 333-252074 | 0001628280-22-012012 |
| 2021-01-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1598599/999999999521000330/9999999995-21-000330-index.htm) Declared effective | 333-252074 | 9999999995-21-000330 |
| 2021-01-13 | [F-3](https://www.sec.gov/Archives/edgar/data/1598599/000162828021000427/0001628280-21-000427-index.htm) Shelf registered | 333-252074 | 0001628280-21-000427 |
| 2019-10-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1598599/000119312519270053/0001193125-19-270053-index.htm) Final prospectus | 333-233865 | 0001193125-19-270053 |
| 2019-10-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1598599/999999999519002357/9999999995-19-002357-index.htm) Declared effective | 333-234063 | 9999999995-19-002357 |
| 2019-10-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1598599/999999999519002325/9999999995-19-002325-index.htm) Declared effective | 333-233865 | 9999999995-19-002325 |
| 2019-10-04 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1598599/000119312519262824/0001193125-19-262824-index.htm) Amendment | 333-233865 | 0001193125-19-262824 |
| 2019-09-20 | [F-1](https://www.sec.gov/Archives/edgar/data/1598599/000119312519250682/0001193125-19-250682-index.htm) Registration filed | 333-233865 | 0001193125-19-250682 |
| 2019-06-10 | [DRS](https://www.sec.gov/Archives/edgar/data/1598599/000095012319005898/0000950123-19-005898-index.htm) Draft made public | 377-02690 | 0000950123-19-005898 |

[All filings of this company](https://equitycapital.markets/filings?cik=1598599) · [CSV](https://equitycapital.markets/filings.csv?cik=1598599)

---
Source page: https://equitycapital.markets/company/1598599 · Data: U.S. SEC EDGAR · CC BY 4.0